A recent study revealed a significant up-regulation of the m7G tRNA methyltransferase METTL1/WDR4 in HCC cells upon lenvatinib treatment, leading to dysregulation of tRNA expression abundance. The gene discussed is METTL1; the disease is hepatocellular carcinoma.